US FDA approves Moderna’s Covid-19 vaccine, Spikevax in children aged 6 months through 11 years at increased risk for Covid-19 disease: Cambridge, Massachusetts Saturday, July 1 ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

The Expanded Programme on Immunization (EPI) under the Sindh Health Department, has intensified preparations for Big Catch-Up ...

Japan has pledged $5 million through UNICEF to immunize 13 million children in Afghanistan against polio, reinforcing its ...

Emergency vaccination campaigns have slashed deaths from major infectious disease outbreaks by nearly 60 per cent since 2000, ...

As national cases soar and federal leadership engages in vaccine skepticism, Illinois has so far seen a single, small measles outbreak this year that health officials say they quickly brought ...

Kennedy selected a new team of medical professionals and scientists who are looking at vaccines are highly qualified.

The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval ...

The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one ...

DOJ filed the statement of interest in United States District Court for the case Children’s Health Defense et al. v. Washington Post et al., which lists among its defendants the BBC, Reuters, the ...

The U.S. Food and Drug Administration approved "Spikevax," Moderna's vaccine for children aged 6 months to 11 years old. The ...